Archives of Disease in Childhood最新文献

Background and objective: Most children with the rare disorder Silver-Russell syndrome (SRS) have feeding difficulties and/or gastrointestinal symptoms such as vomiting and constipation, worsening their postnatal growth. Whether the complaints remain in adult life has not been evaluated by large specialised national centres.

Design/setting/patients: All 28 individuals who were referred to the national centre for SRS as children were approached at an adolescent or adult age. We used the validated Gastrointestinal Symptom Rating Scale (GSRS) questionnaire to assess gastrointestinal symptoms during the last week. Individuals with the most bothersome gastrointestinal symptoms completed the Rome IV Diagnostic Questionnaires online, General Anxiety Disorder-7, the Patient Health Questionnaire-9, the Patient Health Questionnaire-12 Somatic Symptom scale and the Patient-Reported Outcomes Measurement Information System Global-10.

Results: The GSRS questionnaires were completed by 18 individuals from the age of 14 years. There was at least one gastrointestinal symptom of moderate severity reported by 11 (61%) individuals. The most frequent symptom domain was related to 'Indigestion' (27%), 'Reflux' (22%) and 'Constipation' (22%). Among 11 individuals with at least one gastrointestinal symptom of moderate severity, six completed the Rome IV Diagnostic Questionnaires and five were diagnosed with a disorder of gut-brain interaction.

Conclusion: Short-term gastrointestinal symptoms are common in young adults diagnosed with SRS. This needs to be further evaluated in prospective studies assessing the chronicity of the symptoms.

Objective: This study aimed to explore health professionals' perspectives on the management of preschool wheeze, including their views on using tests to guide treatment for children with recurrent wheeze.

Design: Purposive and snowball sampling were used in this qualitative study to recruit health professionals with experience of managing children with pre-school wheeze from primary and secondary care settings across England. Semi-structured interviews were conducted via Microsoft Teams. Transcripts were analysed thematically, supported by the use of NVivo software, to identify key themes.

Results: 14 health professionals participated: four general practitioners, four general paediatricians, four hospital asthma nurses, one tertiary respiratory paediatrician and one primary care nurse. Participants agreed that preschool wheeze remains a significant disease. Thematic analysis identified four key themes: (1) challenges with diagnostic terminology, where a lack of consistent terminology was considered to impact communication and management; (2) diagnostic uncertainty, where the absence of objective tests for early asthma diagnosis negatively contributed to management plans; (3) current practice of investigating children with preschool wheeze, where participants described a lack of infrastructure and approach to performing tests in primary and secondary care; and (4) treatment considerations in which parents' medication beliefs were thought to influence adherence to prescribed treatments. There were differences in the views regarding the management of preschool wheeze between primary and secondary care professionals.

Conclusion: Health professionals' views highlight inconsistent use of diagnostic terminology for preschool wheeze, contributing to variation in management. Integrated care pathways and infrastructure are urgently needed to improve outcomes for children with preschool wheeze.

Objectives: To estimate the association between maternal perinatal mood and anxiety disorder (PMAD) symptoms and infant health-related quality of life (HRQoL).

Design: Retrospective cohort study.

Setting: Maternal survey data representative of all live births in 2020 in three US states (Kansas, New Jersey and Virginia).

Exposures: Early (4-6 months postpartum) and late (12-14 months postpartum) PMAD symptoms.

Main outcome measures: Survey-weighted adjusted logistic regression models estimated the association between maternal PMAD symptoms and parent-reported infant HRQoL measures including overall health, physical limitations and multiple domains of growth and development at 12-14 months.

Results: Maternal postpartum PMAD symptoms were associated with increased odds of parent-reported mediocre or bad infant health (9.4% v 4.3%, aOR 2.1 (1.1-3.9)) and at least one growth and development problem (19.2% vs 13.0%, aOR 1.7 (1.1-2.7)), but not with infant physical functioning. Differences in infant growth and development were larger for mothers with late postpartum PMAD symptoms compared with those with no or only early PMAD symptoms. Greater differences were also reported by parents experiencing anxiety symptoms compared with those with only depressive symptoms.

Conclusions: Maternal PMAD symptoms were associated with perceived differences in infant health, growth and development, particularly in the late postpartum period. This association may arise from a causative relationship between PMAD and infant development: conversely, infant health concerns may drive PMAD symptoms. Both mechanisms support the need for screening, diagnosis and treatment for parental anxiety and depression beyond the early postpartum period.

As Archives of Disease in Childhood approaches its 100th anniversary, we describe in this article how the understanding of the aetiology, epidemiology, parent-infant interactions and approaches to prevention of unexpected deaths in infancy has evolved over the century.We have been involved in research into unexpected infant deaths, support of bereaved families and prevention of such deaths since 1976 (PF), 1992 (PB) and 2006 (AP).

We present 19 judgments of English courts; all that we could find relating to the refusal of blood transfusion by or on behalf of children of Jehovah's Witness families.This provides detailed context to clinicians faced with this dilemma.Our review identifies demographic patterns of applications to the court: the broad separation into infants and capable teenagers; their underlying diagnosis; proximity to majority; prognosis; their independent capability to refuse life-saving treatment. The positions taken by the applicant trusts, the parents, the children themselves and the clinicians seeking permission compulsorily to transfuse also form patterns, together with the judicial response and the demonstrable evolution of judicial thinking.Without these thematic patterns, it would not be possible to provide generic guidance for patients, their families, clinicians or trust managers, as to what factors should be considered when facing the situation where a child or her family is refusing treatment that may save life or prevent irremediable harm.Our conclusions, based on the emerging patterns, including the benefits of centralising clinical judgement relating to compulsory transfusion in paediatric haematology/oncology centres; the suggestion of specific research (including to determine how the judges in these cases reached a conclusion on the individual teenager's capacity to make the choices that they advanced to the court) and avoiding the temptation to seek a rolling or enduring authority to compel transfusion.These and other patterns and conclusions provide guidance as to what should be considered if contemplating an application for judgement in these circumstances.

Objective: We evaluated the long-term association between the COVID-19 pandemic and the language development of children aged 18 months by comparing prepandemic and pandemic periods in Japan.

Study design: This repeated cross-sectional study included 39 840 children attending 18-month health check-ups conducted by the Okayama City Public Health Center (January 2017-March 2024). We compared language development indicators before (January 2017-March 2020) and during (April 2020-March 2024) the pandemic, with the latter divided into early (April 2020-March 2022) and late (April 2022-March 2024) periods. The primary outcome was the proportion of children requiring language development follow-up (children who did not meet any one of the three questions on language development). The secondary outcome was the proportion of children who could not say ≥3 meaningful words (one of the three questions). Risk ratios (RRs) and 95% CIs were estimated adjusting for confounders, with subgroup analyses by sex, childcare location (home, nursery school) and family size (≤3, ≥4).

Results: Compared with the prepandemic period, increased RRs were observed during the pandemic: 1.19 (95% CI 1.15 to 1.22) for the primary outcome and 1.16 (95% CI 1.11 to 1.22) for the secondary outcome. RRs were higher in the late than in the early period. Adverse associations were more pronounced in girls than boys, and in children cared for at home.

Conclusion: The long-term association between the pandemic and language development at 18 months suggests the need for more comprehensive support for high-risk families.

Objective: This study aimed to examine whether biomarker tests-finger-prick, skin-prick and offline fractional exhaled nitric oxide (FeNO)-are acceptable and feasible as a guide to treatment decisions, uniquely combining the perspectives of parents of preschool children with wheeze and healthcare professionals (HCPs) working in National Health Service (NHS) primary care.

Design: Qualitative interview study. Criterion sampling was used to recruit 16 parents from 16 families, and convenience sampling to recruit 16 HCPs (doctors and nurses) from 14 primary care NHS practices. Qualitative data were collected via online one-to-one interviews and focus groups (FGs), conducted on Microsoft Teams, transcribed and thematically analysed within the NVivo software package.

Results: Parents described the biomarker tests as acceptable when they were supported by evidence of effectiveness and empathetic communication from HCPs. Skin-prick testing was the most preferred test by parents as it helped them minimise allergen exposures. HCPs favoured finger-prick and FeNO tidal breathing test due to greater familiarity and feasibility in primary care. Time constraints, cost of devices and training to perform the biomarker tests were reported as barriers to implementation. Both groups agreed that testing frequency should depend on wheeze severity. Finally, a proposed future randomised controlled trial examining whether a biomarker-based approach is superior to the current symptom-based approach was regarded as acceptable and feasible.

Conclusion: Finger-prick, skin-prick and FeNO testing are conditionally acceptable and feasible in clinical practice for preschool wheeze. However, there should be evidence of their effectiveness, empathetic communication between parents and HCPs and tests' cost-effectiveness to support NHS funding.